Navigation Links
Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
Date:6/2/2008

clusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding Isis' business, its drug discovery and development pipeline, and the therapeutic potential of LY2181308 and OGX-011 for the treatment of cancer. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2007, and its quarterly report on Form 10-Q for the quarter ended March 31, 2008, which are on file with the SEC. Copies of this and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries.

Isis Pharmaceuticals is a registered trademark of Isis Pharmaceuticals, Inc. Ibis Biosciences
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
2. Briefing on a new Web resource to address global drinking water crisis
3. St. Petersburg: Candlelight Vigil to Raise Awareness of Florida HIV/AIDS Crisis, Honor Lives Lost
4. Isis Acquires Symphony GenIsis
5. New Denver Area Program Developed For Teens in Crisis
6. Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
7. March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis
8. March of Dimes NICU Family Support(R) Programs Give Florida Families Comfort and Information During a Crisis
9. Isis Reports That ISIS 301012 is Well Tolerated in Patients Treated for Five Or More Months
10. Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
11. Survey of Iowa Voters Reveals Surprising Results and Attitudes Toward Americas Health Care Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...any people are still not very much aware of oral c...s account for about 4% of all malignancies. //The ... early diagnosis often leads to a cure. But, as a ...niversity shows, not everyone is aware of the risk...
...tle difference in outcome between radical and more...my - total removal of the breast and the nodes und...as a treatment for breast cancer. Surgeons are mor... lumpectomy, which just removes the lump and conse...
... your blood clot properly.It is so important that ...r birth to prevent bleeding. The vitamin is found...de by bacteria //in the intestine.Since newborns d...y need supplemental vitamin K. An Adequate Intake ...
...rchers have found that the bone marrow cell transp...s in the US have been studying the ability of huma...o restore function in brain-damaged rats. Animals ...ich came from healthy human volunteers. Compared ...
Other Medicine News:
(Date:10/6/2008)...a from SONIC Trial Showed REMICADE Therapy is More...osal Healing Compared with Standard ...., Oct. 6 /- Data presented for the f... Crohn,s Disease Naive to,Immunomodulators and Bio...o,the approach to care of patients with moderate t...
(Date:10/6/2008)...re than 60 percent of moderate to severe patients ...ent achieved endoscopic remission at Week 10,in da...e American College,of Gastroenterology (ACG) Annua...wswire/ -- UCB today presented data from a,large, ...ment in Crohn,s,disease (CD) with a biologic compo...
(Date:10/6/2008)...- TARGIT Procedure May Eliminate 6 Weeks of Radiat...Treatment over the Internet Wednesday, October ...ra.com/explorehealth , HAMPTON, Va., Oct. 6 /PRNe... when she was diagnosed with breast cancer in May....east? How about radiation or chemotherapy?, , To...
(Date:10/6/2008)...cent study revealed that drinking polyphenol-rich ...hanges in appetite, energy intake or body,weight, ...nsumption of 100%,polyphenol-rich Concord grape ju... associated with changes in appetite and was shown...ta presented at the 49th Annual Meeting of,the Ame...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 1CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 2CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 1American Chemical Societys Weekly PressPac Feb 6 2008 11486 2American Chemical Societys Weekly PressPac Feb 6 2008 11486 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 5American Chemical Societys Weekly PressPac Feb 6 2008 11486 6American Chemical Societys Weekly PressPac Feb 6 2008 11486 7American Chemical Societys Weekly PressPac Feb 6 2008 11486 8American Chemical Societys Weekly PressPac Feb 6 2008 11486 9HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 1HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 2HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 3Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 1Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 2Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 3Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 4
..., 2007--The costs of eradicating,poliomyelitis fro...the short term, are much lower than the long term ...ication. And a recently developed,monovalent vacci...pe 1 poliomyelitis than an existing trivalent vacc...hed Online and in an upcoming,issue of The Lancet....
..., April 11, 2007 /PRNewswire-FirstCall/ --,Advance...two,additional Phase III clinical trials of ferumo...apeutic that are being,presented today at approxim...y Foundation,s Spring Clinical Meeting in Orlando,...tor section on the,company,s web site at <a target...
Other Medicine Technology:Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 2Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 4Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 5Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 6Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 7Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 8
MVR Blades for water tight self sealing incision.
Lens Plus Daily Cleaner is the preservative-free daily cleaner for soft contact lenses.
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro
Medicine Products: